Attenuation of stress-induced behavioral deficits by lithium administration via serotonin metabolism

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 336-342

  Perveen, Tahira ^a   Haider, Saida ^a   Mumtaz, Wajeeha ^a   Razi, Faiza ^a   Tabassum, Saiqa ^a   Haleem, Darakhshan J ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

5 HT; Behavior; Lithium; Stress

Indexed keywords

LITHIUM CARBONATE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION STRESS; LOCOMOTION; MEMORY; MEMORY DISORDER; NEUROCHEMISTRY; NONHUMAN; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; STRESS; TASK PERFORMANCE;

EID: 84879361128     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(13)71008-9     Document Type: Article

References (50)

1. Amat J, Sparks PD, Matus AP, Griggs J, Watkins LR, Maier SF: The role of habenular complex in the elevation of dorsal raphe nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress. Brain Res, 2001, 917, 118-126.
2. Baker KB, Kim JJ: Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn Mem, 2002, 9, 58-65.
3. Bhattacharya SK, Das Neeta, Sarkar MK: Inhibition of carrageenin-induced pedal oedema in rats by immobilization stress. Res Exp Med, 1987, 187, 303-313.
4. Bearden CE, Thompson PM, Dutton RA, Frey BN, Peluso MA, Nicoletti M, Dierschke N: Three dimen-sional anatomy of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology, 2003, 33, 1229-1238.
5. Camins A, Verdaguer E, Junyent F, Yeste-Velasco M, Pelegrí C, Vilaplana J, Pallás M: Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci Ther, 2009, 15, 333-344.
6. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA, 1992, 267, 1244-1252.
7. El-Mallakh S: Lithum: Actions and Mechanisms. American Psychiatric Press, Washington, DC, 1996.
8. Ennaceur A, Delcour J: A new one trial test for neurobiological studies of memory in rats.1: Behavioral data. Behav Brain Res, 1988, 31, 47-59.
9. Gray P, Solomon J, Dumpy M, Carr F, Hession M: Effects of lithium on open field behavior in "stressed" and "unstressed" rats. Psychopharmacology, 1976, 48, 277-281.
10. Haider S, Khaliq S, Ahmed SP, Haleem DJ: Long term tryptophan administration enhances cognitive performance and increases 5HT metabolism in the hippocampus of female rats. Amino Acids, 2006, 31, 421-425.
11. Haleem DJ, Haider S. Food restriction decreases serotonin and it's synthesis rate in hypothalamus. Neuroreport, 1996, 7, 1153-1156.
12. Haleem DJ, Kennett GA, Curzon G: Adaptation of female rats to stress: shift to female pattern by inhibition of corticosterone synthesis. Brain Res, 1988, 458, 339-347.
13. Haleem DJ, Naz H, Parveen T, Haider S, Ahmed SP, Khan NH, Haleem MA: Serotonin and serotonin 1.A receptors in the failure of ethanol-treated rats to adapt a repeated stress schedule. J Stud Alcohol, 2002, 63, 389-396.
14. Haleem DJ, Perveen T: Brain regional serotonin synthesis following adaptation to repeated restraint. Neuroreport, 1994, 5, 1785-1788.
15. Haleem DJ, Samad N, Parveen T, Haider S, Haleem MA: Role of serotonin 1A receptors in restraint induced behavioral deficits and adaptation to repeated restraintstress in rats. Int J Neurosci, 2007, 117, 243-257.
16. Hughes JH, Gallagher P, Young AH: Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients. Eur Neuropsychopharmacol, 2002, 12, 123-128.
17. Karimfar MH, Tabrizian K, Azami K, Hosseini-Sharifabad A, Hoseini A, Pourghorban M, Aghsami M et al.: Time course effects of lithium administration on spatial memory acquisition and cholinergic marker expression in rats. DARU, 2009, 17, 113-123.
18. Kennett GADickinson SL, Curzon G: Central serotonergic responses and behavioral adaptation to repeated immobilization: the effect of the corticosterone synthesis inhibitor metyrapone. Eur J Pharmacol, 1985, 119, 143-152.
19. Kennett GA, Dourish CT, Curzon G: Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol, 1987, 134, 265-274.
20. Kennett GA, Stephen LD, Curzon G: Enhancement of some 5-HT depressant behavioral responses following repeated immobilization in rats. Brain Res, 1985, 330, 253-263.
21. Krahn DD, Gosnell BA, Levine AS, Morley JE: Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res, 1988, 443, 63-69.
22. Lim KY, Yang JJ, Lee DS, Noh JS, Jung MW, Chung YK: Lithium attenuates stress-induced impairment of long-term potentiation induction. Neuroreport, 2005, 28, 1605-1608.
23. Marmol F: Lithium: bipolar disorder and neurodegenerative diseases. Possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32, 1761-1771.
24. Maroun M, Levin GR: Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo. J Neurosci, 2003, 23, 4406-4409.
25. McQuillin A, Riziq M, Gurling HM: A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics, 2007, 17, 605-617.
26. Millan MJ, Dekeyne A, Gobert A: Serotonin 5-HT2c receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology, 1998, 37, 953-955.
27. Miller JC, Jiménez P, Mathé AA: The international restraint stress influences AP-1 and CREB DNA-binding activity induced by chronic lithium treatment in the rat frontal cortex and hippocampus. Int J Neuropsychopharmacol, 2007, 10, 609-619.
28. Moa B, Fenga N, Rennera K, Forsterb G: Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res Bull, 2008, 76, 493-498.
29. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Menji HK: Lithium-induced increase in human brain grey matter. Lancet, 2000, 356, 1241-1242.
30. Mushtaq F, Haider S, Perveen T, Haleem DJ: Lack of restraint-induced increases of brain serotonin metabolism in rats treated with spiperone: relationship with restraint-induced behavioral deficits. Pak J Pharm Sci, 2004, 17, 57-65.
31. Naughten M, Mulrooney JB, Leonard BE: A role of the serotonin receptors in psychiatric disorders. Hum Psychopharmacol, 2000, 15, 397-415.
32. Paré WP, Glavin GB: Reviews restraint stress in biomedical research. Neurosci Biobehav Rev, 1986, 10, 339-370.
33. Perez-Cruet J, Taqliamonte A, Taqliamonte P, Gessa GL: Stimulation of serotonin synthesis by lithium. J Pharmacol Exp Ther, 1971, 178, 325-330.
34. Pessia M, Jiang ZG, Alan RA, Johnson SW: Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res, 1994, 654, 324-330.
35. Porter RJ, Lunn BS, O'Brien JT: Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly. Psychol Med, 2003, 33, 41-49.
36. Post RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry, 1992, 149, 999-1010.
37. Quiroz JA, Gould TD, Manji HK: Molecular effects of lithium. Mol Interv, 2004, 4, 259-272.
38. Samad N, Parveen T, Haider S, Haleem DJ: Effect of repeated injection of Neem leaf extract and restraint stress on model of anxiety and brain serotonin metabolism in rats. Hamdard Medicus, 2002, 45, 54-58.
39. Samad N, Perveen T, Haider S, Haleem MA, Haleem DJ: Inhibition of restraint-induced neuroendocrine and serotonergic responses by buspirone in rats. Pharmacol Rep, 2006, 58, 636-642.
40. Serretti A, Lilli R, Mandelli R, Lorenzi C, Smelardi E: Serotonin transporter gene is associated with lithium prophylaxis in mood disorder. Pharmacogenomics J, 2001, 1, 71-77.
41. Sheard MH, Aghajanian GK: Neuronally activated metabolism brain serotonin: Effect of lithium. Life Sci, 1970, 9, 285-290.
42. Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leão P, Almeida OF, Sousa N: Lithium blocks stressinduced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthasekinase-3b. Neuroscience, 2008, 152, 656-669.
43. Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ: Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science, 2010, 1307, 14-21.
44. Tsaltasa E, Kontis D, Boulougouris V, Papakostaa VM, Giannou H, Poulopoulou C, Soldatos C: Enhancing effects of chronic lithium on memory in the rat. Behav Brain Res, 2007, 177, 51-60.
45. Tsaltas E, Kontis D, Boulougouris V, Papadimitriou GN: Lithium and cognitive enhancement: leave it or take it? Psychopharmacology (Berl), 2009, 202, 457-476.
46. Vasconcellos APS, Tabajara AS, Ferrari C, Rucha E, Dalmaz C: Effect of chronic stress on spatial memory in rats is attenuated by lithium treatment. Physiol Behav, 2003, 79, 143-149.
47. Villegier AS, Salomon L, Blanc G, Godeheu G, Glowinski J, Tassin JP: Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotinein mice. Eur J Neurosci, 2006, 24, 1359-1365.
48. Wada A, Yokoo H, Yanagita T, Kobayashi H: Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci, 2005, 99, 307-321.
49. Wada AJ: Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3b, b-catenin, and neurotrophin cascades. J Pharmacol Sci, 2009, 110, 14-28.
50. Wong ML, Licinio J: Research and treatment approaches to depression. Nat Rev Neurosci, 2001, 2, 343-351.